The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous(IV) Therapy and Vein Access Market Research Report 2025
Synopsis
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous(IV) Therapy and Vein Access market was valued at US$ 35670 million in 2023 and is anticipated to reach US$ 46480 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous(IV) Therapy and Vein Access.
Report Scope
The Intravenous(IV) Therapy and Vein Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous(IV) Therapy and Vein Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous(IV) Therapy and Vein Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous(IV) Therapy and Vein Access market was valued at US$ 35670 million in 2023 and is anticipated to reach US$ 46480 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous(IV) Therapy and Vein Access.
Report Scope
The Intravenous(IV) Therapy and Vein Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous(IV) Therapy and Vein Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous(IV) Therapy and Vein Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infusion Pumps
1.2.3 Implantable Ports
1.2.4 Intravenous Catheters
1.2.5 Hypodermic Needles
1.2.6 Other
1.3 Market by Application
1.3.1 Global Intravenous(IV) Therapy and Vein Access Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous(IV) Therapy and Vein Access Market Perspective (2019-2030)
2.2 Intravenous(IV) Therapy and Vein Access Growth Trends by Region
2.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2019-2024)
2.2.3 Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Region (2025-2030)
2.3 Intravenous(IV) Therapy and Vein Access Market Dynamics
2.3.1 Intravenous(IV) Therapy and Vein Access Industry Trends
2.3.2 Intravenous(IV) Therapy and Vein Access Market Drivers
2.3.3 Intravenous(IV) Therapy and Vein Access Market Challenges
2.3.4 Intravenous(IV) Therapy and Vein Access Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue
3.1.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue (2019-2024)
3.1.2 Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Players (2019-2024)
3.2 Global Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous(IV) Therapy and Vein Access Revenue
3.4 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio
3.4.1 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous(IV) Therapy and Vein Access Revenue in 2023
3.5 Intravenous(IV) Therapy and Vein Access Key Players Head office and Area Served
3.6 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
3.7 Date of Enter into Intravenous(IV) Therapy and Vein Access Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous(IV) Therapy and Vein Access Breakdown Data by Type
4.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2019-2024)
4.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2025-2030)
5 Intravenous(IV) Therapy and Vein Access Breakdown Data by Application
5.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2019-2024)
5.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
6.2 North America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
6.4 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
7.2 Europe Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
7.4 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
8.2 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024)
8.4 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
9.2 Latin America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
9.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
10.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
10.4 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun
11.1.1 B. Braun Company Detail
11.1.2 B. Braun Business Overview
11.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Introduction
11.1.4 B. Braun Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.1.5 B. Braun Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Introduction
11.2.4 Baxter International Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.2.5 Baxter International Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Introduction
11.3.4 Becton Dickinson Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Detail
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Introduction
11.4.4 C. R. Bard Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.4.5 C. R. Bard Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Detail
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Introduction
11.5.4 Fresenius Kabi Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.5.5 Fresenius Kabi Recent Development
11.6 Hospira(ICU Medical)
11.6.1 Hospira(ICU Medical) Company Detail
11.6.2 Hospira(ICU Medical) Business Overview
11.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Introduction
11.6.4 Hospira(ICU Medical) Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.6.5 Hospira(ICU Medical) Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Introduction
11.7.4 Medtronic Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 Smiths Group
11.8.1 Smiths Group Company Detail
11.8.2 Smiths Group Business Overview
11.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Introduction
11.8.4 Smiths Group Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.8.5 Smiths Group Recent Development
11.9 Teleflex
11.9.1 Teleflex Company Detail
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Introduction
11.9.4 Teleflex Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.9.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
